Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment

BACKGROUND: There are limited data available on the treatment and outcome of epidermal growth factor receptor (EGFR) exon 20-mutated lung cancer patients. Hence, we planned an analysis of the demographic details, clinical profile and survival of lung cancer patients with exon 20 mutations. We compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Noronha, Vanita, Choughule, Anuradha, Patil, Vijay M, Joshi, Amit, Kumar, Rajiv, Susan Joy Philip, Deepa, Banavali, Shripad, Dutt, Amit, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476719/
https://www.ncbi.nlm.nih.gov/pubmed/28652772
http://dx.doi.org/10.2147/OTT.S133245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476719/
https://www.ncbi.nlm.nih.gov/pubmed/28652772
http://dx.doi.org/10.2147/OTT.S133245

Ejemplares similares